TCS, HDFCBANK, SBI Liquid Fund (G)
Suven Life Sciences Ltd.
Suven Life Sciences
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 04 05 2021 | Audited Results |
| 09 08 2021 | Quarterly Results |
| 25 10 2021 | Quarterly Results |
| 31 01 2022 | Quarterly Results |
| 07 05 2022 | Audited Results |
| 24 06 2022 | Rights Issue & Inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company in accordance with provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other matters related/ incidental thereto including the constitution of a Committee of Board of Directors namely ?Rights Issue Committee? to implement the proposal of Rights Issue. |
| 26 07 2022 | Quarterly Results |
| 12 10 2022 | Right Issue of Equity Shares |
| 10 11 2022 | Quarterly Results |
| 02 02 2023 | Quarterly Results |
| 09 05 2023 | Quarterly Results & Audited Results |
| 08 08 2023 | Quarterly Results |
| 04 11 2023 | Quarterly Results |
| 30 01 2024 | Quarterly Results |
| 29 10 2024 | Quarterly Results |
| 24 01 2025 | Quarterly Results |
| 13 05 2025 | Preferential Issue of shares & Issue Of Warrants & Audited Results |
News
No News data available
